Skip to main content
Clinical Trials/NCT01975207
NCT01975207
Completed
N/A

Comparison Study of Family Practice Interventions for Depression in Adults

AHS Cancer Control Alberta0 sites1,489 target enrollmentNovember 2013
ConditionsDepression

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
AHS Cancer Control Alberta
Enrollment
1489
Primary Endpoint
Reduction in depression scores in those patients who have one of the two treatment interventions
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To determine if treatment of significant depressive symptoms identified in individuals attending a family practice improves either psychiatric outcome, overall health care costs, or Quality of Life (QOL). Two previously developed treatment approaches - an internet-based approach and a comprehensive depression pathway - will be compared to two control groups (those who have treatment as usual after screening for depression and measurement of QOL, and a second control group who will have QOL data only collected). The investigators hope to help Alberta Health Services identify which approach is best as rapidly as possible so that the best approach can be implemented throughout the province of Alberta.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
May 5, 2015
Last Updated
5 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 and above
  • Cognitively capable of independently understanding and confirming their desire to take part

Exclusion Criteria

  • 18 and under
  • Cognitively incapable of independently understanding and confirming their desire to take part

Outcomes

Primary Outcomes

Reduction in depression scores in those patients who have one of the two treatment interventions

Time Frame: 12 weeks

We expect a reduction in depression scores in those patients who have one of the two treatment interventions (Groups #3 and #4) over a 12-week period, compared to those who are screened for depression, but only receive treatment as usual (Group #2).

Secondary Outcomes

  • Reduction in total health care costs(12 weeks/12 months)

Similar Trials